A steroid modulatory domain in NR2A collaborates with NR1 exon-5 to control NMDAR modulation by pregnenolone sulfate and protons

Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential

(2009) Laetitia Mony et al.   BRITISH JOURNAL OF PHARMACOLOGY

Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes

(2009) Juan E Belforte et al.   NATURE NEUROSCIENCE

Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia

(2009) Christine E Marx et al.   NEUROPSYCHOPHARMACOLOGY

Neuroactive steroid regulation of neurotransmitter release in the CNS: Action, mechanism and possible significance

(2009) Ping Zheng   PROGRESS IN NEUROBIOLOGY

Pregnenolone sulfate induces NMDA receptor dependent release of dopamine from synaptic terminals in the striatum

(2008) Matthew T. Whittaker et al.   JOURNAL OF NEUROCHEMISTRY

Zinc inhibition of rat NR1/NR2AN-methyl-d-aspartate receptors

(2007) Kevin Erreger et al.   JOURNAL OF PHYSIOLOGY-LONDON

Pregnenolone sulfate in the brain: A controversial neurosteroid

(2007) Michael Schumacher et al.   NEUROCHEMISTRY INTERNATIONAL